UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 5, 2014

 

 

EBIX, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		0-15946		77-0021975
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)
5 Concourse Parkway, Suite 3200, Atlanta, Georgia				30328
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s telephone number, including area code: (678) 281-2020

Not Applicable

(Former name or former address if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.02

Compensatory Arrangements of Certain Officers.

On May 5, 2014, the board of directors of Ebix, Inc., upon the recommendation of its Compensation Committee, increased the base salary of James Senge, Sr., Senior Vice President – EBIX Health, to $225,000 per year from $200,000. The increase in base salary is effective May 5, 2014.

[Rest of Page Intentionally Blank. Signature on following Page.]

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 7, 2014